DLX GENE REGULATION OF OSTEOBLAST DIFFERENTIATION
成骨细胞分化的 DLX 基因调控
基本信息
- 批准号:7022325
- 负责人:
- 金额:$ 29.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-08 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:DNA binding proteinRNA interferencebiological signal transductionbone developmentcell differentiationcraniofacialgene induction /repressiongene targetinggenetic promoter elementgenetic regulationgenetically modified animalsin situ hybridizationlaboratory mousemicroarray technologynorthern blottingsosteoblastsskeletal system
项目摘要
DESCRIPTION (provided by applicant):
The goal of our studies is to contribute to the understanding of the transcriptional regulation of osteoblastic differentiation. This is crucial to our understanding of the mechanisms controlling bone formation. Greater understanding of this process may lead to more rational design of therapies for osteoporosis and other bone diseases. Our studies and those of others have suggested that Dlx5, a homeodomain-containing transcription factor, plays an important role in the induction of osteoblastic differentiation. The Specific Aims of this grant application are: 1. To assess the role of Dlx5 in osteoblast differentiation in vivo by studying the effect of over expression of Dlx5 in osteoblasts off transgenic mice at different stages of osteoblast lineage progression. 2. To study the effect of inactivation of Dlx5 in cultured osteoblasts, and to assess the effect of Dlx5 on osteoblastic gene expression. We will study in vitro differentiation of osteoblasts derived from Dlx5 knockout mice. We will also carry out focused microarray analysis of cells plus and minus Dlx5 to identify genes that are induced or inhibited by Dlx5, and analyze bone development in an osteoblast directed knockout of the Dlx5 gene. This will allow us to separate the effects of Dlx5 expression in osteoblasts from the effect of this gene in other cell types. 3. To assess the potential for other members of the Dlx gene family to contribute to induction of osteoblast differentiation in vivo. We will continue to examine the expression of Dlx1, 2,3, 6 and 7 in osteoblasts. We will continue studies on Dlx3, which we already have detected in differentiating osteoblasts. We will continue studies on the ability of other Dlx genes to induce osteoblastic differentiation in the same in vitro system that we have used to study Dlx5. We will also study an osteoblast-directed knockout of the Dlx3 gene, to evaluate the role of Dlx3 in bone development in vivo. Our proposed studies will contribute to a more complete understand of the role of the Dlx protein family in osteoblast differentiation.
描述(由申请人提供):
我们的研究目的是为了解成骨细胞分化的转录调控做出贡献。这对我们理解控制骨形成的机制至关重要。更好地理解这一过程可能会导致更合理的设计治疗骨质疏松症和其他骨骼疾病。我们的研究和其他人的研究表明,Dlx5,一个含有同源结构域的转录因子,在诱导成骨细胞分化中起着重要作用。本补助金申请的具体目的是:1。通过研究Dlx5在转基因小鼠成骨细胞谱系进展的不同阶段过度表达的影响,评估Dlx5在体内成骨细胞分化中的作用。2.目的研究Dlx5基因失活对体外培养成骨细胞的影响,探讨Dlx5基因对成骨细胞基因表达的影响。我们将研究Dlx5基因敲除小鼠成骨细胞的体外分化。我们还将进行细胞加和减Dlx5的聚焦微阵列分析,以鉴定Dlx5诱导或抑制的基因,并分析成骨细胞定向敲除Dlx5基因中的骨发育。这将使我们能够将成骨细胞中Dlx5表达的影响与该基因在其他细胞类型中的影响分开。3.评估Dlx基因家族其他成员在体内诱导成骨细胞分化的潜力。我们将继续检测Dlx 1、2、3、6和7在成骨细胞中的表达。我们将继续研究Dlx3,我们已经在分化成骨细胞中检测到了它。我们将继续研究其他Dlx基因在我们用于研究Dlx 5的相同体外系统中诱导成骨细胞分化的能力。我们还将研究成骨细胞定向敲除Dlx3基因,以评估Dlx3在体内骨发育中的作用。我们提出的研究将有助于更全面地了解Dlx蛋白家族在成骨细胞分化中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander C Lichtler其他文献
Alexander C Lichtler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander C Lichtler', 18)}}的其他基金
Development of iPS cells to study craniometaphyseal dysplasia in humans
开发 iPS 细胞来研究人类颅骨干骺端发育不良
- 批准号:
7713304 - 财政年份:2009
- 资助金额:
$ 29.06万 - 项目类别:
Creating Multi-Gene Reporter Mice Via "Recombineering"
通过“重组工程”创建多基因报告小鼠
- 批准号:
7145213 - 财政年份:2006
- 资助金额:
$ 29.06万 - 项目类别:
Creating Multi-Gene Reporter Mice Via "Recombineering"
通过“重组工程”创建多基因报告小鼠
- 批准号:
7282674 - 财政年份:2006
- 资助金额:
$ 29.06万 - 项目类别:
DLX GENE REGULATION OF OSTEOBLAST DIFFERENTIATION
成骨细胞分化的 DLX 基因调控
- 批准号:
7197331 - 财政年份:2004
- 资助金额:
$ 29.06万 - 项目类别:
DLX GENE REGULATION OF OSTEOBLAST DIFFERENTIATION
成骨细胞分化的 DLX 基因调控
- 批准号:
6882679 - 财政年份:2004
- 资助金额:
$ 29.06万 - 项目类别:
DLX GENE REGULATION OF OSTEOBLAST DIFFERENTIATION
成骨细胞分化的 DLX 基因调控
- 批准号:
7383816 - 财政年份:2004
- 资助金额:
$ 29.06万 - 项目类别:
DLX GENE REGULATION OF OSTEOBLAST DIFFERENTIATION
成骨细胞分化的 DLX 基因调控
- 批准号:
6778677 - 财政年份:2004
- 资助金额:
$ 29.06万 - 项目类别:
Collal Driven Ligand-Regulated Cre Transgenic Mice
Collal 驱动的配体调节 Cre 转基因小鼠
- 批准号:
6442053 - 财政年份:2001
- 资助金额:
$ 29.06万 - 项目类别:
Collal Driven Ligand-Regulated Cre Transgenic Mice
Collal 驱动的配体调节 Cre 转基因小鼠
- 批准号:
6533057 - 财政年份:2001
- 资助金额:
$ 29.06万 - 项目类别:
相似海外基金
Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
- 批准号:
23K10830 - 财政年份:2023
- 资助金额:
$ 29.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10539405 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10688080 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
- 批准号:
DP220101361 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10677770 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
- 批准号:
RGPIN-2019-04411 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
- 批准号:
2143019 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
- 批准号:
486535 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10330828 - 财政年份:2022
- 资助金额:
$ 29.06万 - 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
- 批准号:
2046602 - 财政年份:2021
- 资助金额:
$ 29.06万 - 项目类别:
Continuing Grant